These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15189776)

  • 1. Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens.
    Peroni RN; Orliac ML; Becu-Villalobos D; Huidobro-Toro JP; Adler-Graschinsky E; Celuch SM
    Eur J Pharmacol; 2004 Jun; 493(1-3):151-60. PubMed ID: 15189776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
    Mendizábal VE; Orliac ML; Adler-Graschinsky E
    Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats.
    Orliac ML; Peroni R; Celuch SM; Adler-Graschinsky E
    J Pharmacol Exp Ther; 2003 Jan; 304(1):179-84. PubMed ID: 12490589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of CGRP and prostanoids in the sex-linked differences of vascular anandamide effects in mesenteric beds of Sprague-Dawley rats.
    Peroni RN; Orliac ML; Abramoff T; Ribeiro ML; Franchi AM; Adler-Graschinsky E
    Eur J Pharmacol; 2007 Feb; 557(1):49-57. PubMed ID: 17169358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
    Wheal AJ; Randall MD
    Eur J Pharmacol; 2009 Jan; 603(1-3):79-85. PubMed ID: 19100733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenteric vasodilation mediated by endothelial anandamide receptors.
    Wagner JA; Varga K; Járai Z; Kunos G
    Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
    Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
    J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
    Vanheel B; Van de Voorde J
    J Pharmacol Exp Ther; 2001 Feb; 296(2):322-8. PubMed ID: 11160613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
    Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
    Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
    Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
    Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats.
    Orliac ML; Peroni RN; Abramoff T; Neuman I; Podesta EJ; Adler-Graschinsky E
    Eur J Pharmacol; 2007 Jul; 566(1-3):145-52. PubMed ID: 17482593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.
    Mang CF; Erbelding D; Kilbinger H
    Br J Pharmacol; 2001 Sep; 134(1):161-7. PubMed ID: 11522608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase.
    Ho WS
    Eur J Pharmacol; 2013 Feb; 701(1-3):49-56. PubMed ID: 23340220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum.
    Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
    Wheal AJ; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.